argenx Company Contacts

argenx

http://www.argenx.com
argenx is a global immunology company committed to improving the lives of people living with severe autoimmune diseases. Partnering with leading academic researchers through its Immunology Innovation Program (IIP), argenx is translating immunology breakthroughs into a world-class portfolio of novel... Read More
Contacts

Country

United States

City

Boston

Headquarters

Boston, MA

Profile

Founded

2008

Industry

Biotechnology Research

Size

1001 - 5000

Specialties

Oncology, Autoimmune diseases, Rare Diseases, Antibody based medicines, Immunotherapy, Myasthenia Gravis, Immunology, Pemphigus Vulgaris, Immune Thrombocytopenia, Acute Myeloid Leukemia , high-risk myelodysplastic syndromes, chronic inflammatory demyelinating polyneuropathy

Funding

Total Rounds

10

Last Round

Tue Jul 18 2023

Last Round Series

Post IPO equity

Last Round Raised

$ 1,097,641,460